Jian-yu X. Yang

Shanghai Jiao Tong University 160 Pujian Road
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Precision pain management in pancreatic ductal adenocarcinoma: therapeutic progress and mechanism-based approaches targeting tumor-nerve-immune crosstalk

Precision pain management in pancreatic ductal adenocarcinoma: therapeutic progress and mechanism-based approaches targeting tumor-nerve-immune crosstalk

Journal: Zhonghua yi xue za zhi
Published: August 13, 2026

Construction and validation of immunogenic cell death-related molecular clusters, signature, and immune landscape in pancreatic cancer.

Construction and validation of immunogenic cell death-related molecular clusters, signature, and immune landscape in pancreatic cancer.

Journal: Clinical and experimental medicine
Published: July 18, 2024

The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathway.

The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathway.

Journal: Cancer cell international
Published: October 31, 2023

Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer.

Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer.

Journal: Apoptosis : an international journal on programmed cell death
Published: April 01, 2023

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma.

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 14, 2022

IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer.

IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 22, 2022

SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer.

SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer.

Journal: Cancer letters
Published: November 15, 2021

SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.

SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.

Journal: Molecular oncology
Published: February 05, 2021

Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis.

Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis.

Journal: Nature communications
Published: April 13, 2020

Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma.

Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma.

Journal: Cancer research
Published: August 28, 2019

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.

Journal: World journal of gastroenterology
Published: January 30, 2019

GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner.

GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner.

Journal: Gut
Published: August 27, 2018
Showing 1-12 of 26

Last Updated: 09/26/2026